Michelle Brown

479 total citations
23 papers, 344 citations indexed

About

Michelle Brown is a scholar working on Oncology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Michelle Brown has authored 23 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in General Health Professions. Recurrent topics in Michelle Brown's work include Palliative Care and End-of-Life Issues (7 papers), Ethics in medical practice (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Michelle Brown is often cited by papers focused on Palliative Care and End-of-Life Issues (7 papers), Ethics in medical practice (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Michelle Brown collaborates with scholars based in United Kingdom, United States and Australia. Michelle Brown's co-authors include Christopher C. Silliman, Ernest E. Moore, David J. Ciesla, Walter L. Biffl, S. Gail Eckhardt, N. L. Fox, Giuseppe Curigliano, Julie Good, Sandip Pravin Patel and Chunsheng He and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Molecular Cancer Therapeutics.

In The Last Decade

Michelle Brown

21 papers receiving 336 citations

Peers

Michelle Brown
Anne Maas Netherlands
Anne T. Neff United States
P. Maltby United Kingdom
Mackenzie C. Morris United States
Rudolf M. Moos Switzerland
Namrata Peswani United States
Anne Maas Netherlands
Michelle Brown
Citations per year, relative to Michelle Brown Michelle Brown (= 1×) peers Anne Maas

Countries citing papers authored by Michelle Brown

Since Specialization
Citations

This map shows the geographic impact of Michelle Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Brown more than expected).

Fields of papers citing papers by Michelle Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Brown. The network helps show where Michelle Brown may publish in the future.

Co-authorship network of co-authors of Michelle Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Brown. A scholar is included among the top collaborators of Michelle Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Brown. Michelle Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Jeffrey S., Jason J. Luke, Matteo S. Carlino, et al.. (2024). INTerpath-001: Pembrolizumab with V940 (mRNA-4157) versus pembrolizumab with placebo for adjuvant treatment of high-risk stage II-IV melanoma.. Journal of Clinical Oncology. 42(16_suppl). TPS9616–TPS9616. 9 indexed citations
2.
Brown, Michelle, et al.. (2024). The Legal Violence of Police Calls for Service: Toward New Community Safety Infrastructure. eScholarship (California Digital Library). 4(3).
3.
Shapiro, Geoffrey I., Bristi Basu, Anthony B. El-Khoueiry, et al.. (2023). 821TiP Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PARPis). Annals of Oncology. 34. S542–S542. 2 indexed citations
4.
Brown, Michelle, et al.. (2023). Improving nurses' blood transfusion knowledge and skills. British Journal of Nursing. 32(11). 522–525. 3 indexed citations
5.
Brown, Michelle, et al.. (2023). A Meta-Ethnographic Review of Paid Staff and Volunteers Working together in Palliative Care. Journal of Pain and Symptom Management. 66(6). 656–670.e11.
6.
Powderly, John D., Ryan J. Sullivan, Martin Gutierrez, et al.. (2023). Phase 1/2 study of mRNA-4359 administered alone and in combination with immune checkpoint blockade in adult participants with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS2676–TPS2676. 14 indexed citations
7.
Rottey, Sylvie, Jeffrey Clarke, Kyaw Aung, et al.. (2022). Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors. EUR Research Repository (Erasmus University Rotterdam). 40 indexed citations
8.
Gutierrez, Martin, Georgina V. Long, Claire F. Friedman, et al.. (2020). Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results.. Journal of Clinical Oncology. 38(15_suppl). 3058–3058. 7 indexed citations
9.
Brown, Michelle, et al.. (2019). Preparing students to care for patients at the end of life. University of Derby Online Research Archive. (University of Derby). 2 indexed citations
10.
Clarke, Jeffrey, Lillian L. Siu, Jean‐Pascal Machiels, et al.. (2019). Abstract B057: BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors. Molecular Cancer Therapeutics. 18(12_Supplement). B057–B057. 16 indexed citations
11.
Brown, Michelle. (2016). Palliative Care in Nursing and Healthcare. 1 indexed citations
12.
Brown, Michelle, et al.. (2016). Delirium: assessment and treatment of patients with cancer PART 2. British Journal of Nursing. 25(4). S4–S9. 2 indexed citations
13.
Brown, Michelle, et al.. (2015). Delirium: a diagnostic dilemma. Part 1. British Journal of Nursing. 24(Sup16). S9–S14. 5 indexed citations
14.
Brown, Michelle, et al.. (2014). Interventions in exclusive breastfeeding: a systematic review. British Journal of Nursing. 23(2). 86–89. 21 indexed citations
15.
Brown, Michelle, et al.. (2013). Care at the end of life: how policy and the law support practice. British Journal of Nursing. 22(10). 580–583. 7 indexed citations
16.
Brown, Michelle. (2012). Care and compassion at the end of life. 6(2). 69–73. 1 indexed citations
17.
Awada, Ahmad, Guy Jérusalem, Rob Coleman, et al.. (2011). Antitumor activity in a randomized phase II study comparing two schedules of NKTR-102 in patients (Pts) with pretreated metastatic breast cancer (MBC).. Journal of Clinical Oncology. 29(15_suppl). 1034–1034. 4 indexed citations
18.
Brown, Michelle. (2010). Prostate cancer: how assessment of QoL can improve delivery of care. British Journal of Nursing. 19(17). 1080–1084. 5 indexed citations
19.
Sourkes, Barbara M., Lorry R. Frankel, Michelle Brown, et al.. (2005). Food, Toys, and Love: Pediatric Palliative Care. Current problems in pediatric and adolescent health care. 35(9). 350–386. 35 indexed citations
20.
Moore, Ernest E., et al.. (2000). STORED RED BLOOD CELLS SELECTIVELY ACTIVATE HUMAN NEUTROPHILS TO RELEASE IL-8 AND SECRETORY PLA2. Shock. 13(1). 29–33. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026